- Home
- SPTN vs CRMD Comparison
SPTN vs CRMD Comparison
Compare SPTN & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- CRMD
- Stock Information
- Founded
- SPTN 1917
- CRMD 2006
- Country
- SPTN United States
- CRMD United States
- Employees
- SPTN N/A
- CRMD N/A
- Industry
- SPTN Food Distributors
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- CRMD Health Care
- Exchange
- SPTN Nasdaq
- CRMD Nasdaq
- Market Cap
- SPTN 596.4M
- CRMD 973.3M
- IPO Year
- SPTN N/A
- CRMD 2010
- Fundamental
- Price
- SPTN $26.60
- CRMD $11.40
- Analyst Decision
- SPTN Hold
- CRMD Strong Buy
- Analyst Count
- SPTN 1
- CRMD 7
- Target Price
- SPTN $26.90
- CRMD $17.33
- AVG Volume (30 Days)
- SPTN 1.3M
- CRMD 2.5M
- Earning Date
- SPTN 08-14-2025
- CRMD 08-13-2025
- Dividend Yield
- SPTN 3.27%
- CRMD N/A
- EPS Growth
- SPTN N/A
- CRMD N/A
- EPS
- SPTN N/A
- CRMD 0.28
- Revenue
- SPTN $9,652,685,000.00
- CRMD $82,553,827.00
- Revenue This Year
- SPTN $6.00
- CRMD $238.38
- Revenue Next Year
- SPTN N/A
- CRMD $53.52
- P/E Ratio
- SPTN N/A
- CRMD $41.86
- Revenue Growth
- SPTN 0.26
- CRMD N/A
- 52 Week Low
- SPTN $17.30
- CRMD $3.61
- 52 Week High
- SPTN $26.65
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- SPTN 78.13
- CRMD 39.52
- Support Level
- SPTN $26.37
- CRMD $12.14
- Resistance Level
- SPTN $26.56
- CRMD $17.43
- Average True Range (ATR)
- SPTN 0.29
- CRMD 0.69
- MACD
- SPTN 0.60
- CRMD -0.51
- Stochastic Oscillator
- SPTN 99.45
- CRMD 4.60
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.